Literature DB >> 11535236

Opsoclonus in three dimensions: oculographic, neuropathologic and modelling correlates.

A M Wong1, S Musallam, R D Tomlinson, P Shannon, J A Sharpe.   

Abstract

Opsoclonus is a dyskinesia consisting of involuntary, arrhythmic, chaotic, multidirectional saccades, without intersaccadic intervals. We used a magnetic scleral search coil technique to study opsoclonus in two patients with paraneoplastic complications of lung carcinoma. Eye movement recordings provided evidence that opsoclonus is a three-dimensional oscillation, consisting of torsional, horizontal, and vertical components. Torsional nystagmus was also present in one patient. Antineuronal antibody study revealed the presence of anti-Ta (Ma2 onco-neuronal antigen) antibodies in one patient, which had previously been associated only with paraneoplastic limbic encephalitis and brainstem dysfunction, but not opsoclonus, and only in patients with testicular or breast cancer. Neuropathologic examination revealed mild paraneoplastic encephalitis. Normal neurons identified in the nucleus raphe interpositus (rip) do not support postulated dysfunction of omnipause cells in the pathogenesis of opsoclonus. Computer simulation of a model of the saccadic system indicated that disinhibition of the oculomotor region of the fastigial nucleus (FOR) in the cerebellum can generate opsoclonus. Histopathological examination revealed inflammation and gliosis in the fastigial nucleus. This morphological finding is consistent with, but not necessary to confirm, damage to afferent projections to the FOR, as determined by the model. Malfunction of Purkinje cells in the dorsal vermis, which inhibit the FOR, may cause opsoclonus by disinhibiting it.

Entities:  

Mesh:

Year:  2001        PMID: 11535236     DOI: 10.1016/s0022-510x(01)00564-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  26 in total

1.  Paraneoplastic opsoclonus and cerebellar ataxia related to anti-Ma2 antibody: a case report.

Authors:  Nicolas Mélé; Charlotte Hautefort; Alain Toledano; Jean-Yves Delattre; Dimitri Psimaras
Journal:  J Neurol       Date:  2016-01-11       Impact factor: 4.849

Review 2.  Paraneoplastic syndromes of the CNS.

Authors:  Josep Dalmau; Myrna R Rosenfeld
Journal:  Lancet Neurol       Date:  2008-04       Impact factor: 44.182

3.  Ocular flutter in essential tremor: clinical course and response to primidone.

Authors:  Evangelos Anagnostou; Evangelia Kararizou; Ioannis Evdokimidis
Journal:  J Neurol       Date:  2013-09-24       Impact factor: 4.849

4.  Saccadic oscillations - membrane, model, and medicine.

Authors:  Aasef G Shaikh
Journal:  Expert Rev Ophthalmol       Date:  2012-10

5.  Antibodies to dendritic neuronal surface antigens in opsoclonus myoclonus ataxia syndrome.

Authors:  Jessica A Panzer; Ronan Anand; Josep Dalmau; David R Lynch
Journal:  J Neuroimmunol       Date:  2015-07-26       Impact factor: 3.478

6.  Opsoclonus-myoclonus as a manifestation of Lyme disease.

Authors:  L Peter; J Jung; C Tilikete; P Ryvlin; F Mauguiere
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09       Impact factor: 10.154

7.  Gravity-Independent Upbeat Nystagmus in Syndrome of Anti-GAD Antibodies.

Authors:  Daniel Feldman; Jorge Otero-Millan; Aasef G Shaikh
Journal:  Cerebellum       Date:  2019-04       Impact factor: 3.847

8.  Sustained eye closure slows saccades.

Authors:  Aasef G Shaikh; Aaron L Wong; Lance M Optican; Kenichiro Miura; David Solomon; David S Zee
Journal:  Vision Res       Date:  2010-05-24       Impact factor: 1.886

Review 9.  Saccadic burst cell membrane dysfunction is responsible for saccadic oscillations.

Authors:  Aasef G Shaikh; Stefano Ramat; Lance M Optican; Kenichiro Miura; R John Leigh; David S Zee
Journal:  J Neuroophthalmol       Date:  2008-12       Impact factor: 3.042

10.  Ocular oscillations generated by coupling of brainstem excitatory and inhibitory saccadic burst neurons.

Authors:  Stefano Ramat; R John Leigh; David S Zee; Lance M Optican
Journal:  Exp Brain Res       Date:  2005-01       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.